Funds · 13F filer · New York, NY

Integral Health Asset Management, LLC

$2.4B in 89 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+59.9%S&P 500 +20.9%
3y return+68.0%S&P 500 +68.5%
5y return+47.9%S&P 500 +74.5%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since December 31, 2019: $217 against $232 in the S&P 500.2

Integral Health Asset Management, LLCS&P 500 (SPY)
$80$100$23220192026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
RVMDRevolution Medicines Inc$280.9M11.5%
INSMInsmed Inc$170.6M7.0%+6.7%
CYTKCytokinetics Inc$136.3M5.6%
CVSCvs Health Corp$113.8M4.7%+633.3%
EWTXEdgewise Therapeutics Inc$81.3M3.3%+25.0%
VERAVera Therapeutics Inc$75.1M3.1%+9.4%
AXSMAxsome Therapeutics Inc.$73.4M3.0%+757.1%
CAHCardinal Health Inc$71.3M2.9%+11.1%
Roivant Sciences LtdCUSIP G76279101$70.8M2.9%
RYTMRhythm Pharmaceuticals Inc$61.1M2.5%−8.3%
EWEdwards Lifesciences Corp$56.5M2.3%+267.6%
ALHCAlignment Healthcare Inc$47.6M2.0%−22.3%
MRKMerck & Co Inc$45.0M1.8%−17.6%
DGXQuest Diagnostics Inc$42.4M1.7%+233.3%
Uniqure NvCUSIP N90064101$41.5M1.7%
SRRKScholar Rock Hldg Corp$41.2M1.7%+50.0%
BSXBoston Scientific Corp$38.4M1.6%+63.6%
BTSGBrightspring Health Svcs Inc$38.4M1.6%−56.0%
ABTAbbott Laboratories$36.3M1.5%New
UNHUnitedhealth Group Inc$35.3M1.4%New
LFSTLifestance Health Group Inc$32.1M1.3%−30.2%
NVSNovartis Ag$31.3M1.3%−20.0%
TNGXTango Therapeutics Inc$31.3M1.3%+122.2%
THCTenet Healthcare Corp$30.9M1.3%New
SYRESpyre Therapeutics Inc$28.9M1.2%New

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
RVMDRevolution Medicines IncMarch 31, 2023+764.6%$280.9M
BTSGBrightspring Health Svcs IncSeptember 30, 2024+375.1%$38.4M
CYTKCytokinetics IncJune 30, 2020+261.4%$136.3M
TNGXTango Therapeutics IncDecember 31, 2025+252.8%$31.3M
Roivant Sciences LtdCUSIP G76279101March 31, 2025+250.7%$70.8M
INSMInsmed IncDecember 31, 2023+244.0%$170.6M
DFTXDefinium Therapeutics IncMarch 31, 2026+148.9%$25.9M
CVSCvs Health CorpDecember 31, 2024+130.5%$113.8M
ALHCAlignment Healthcare IncDecember 31, 2024+111.6%$47.6M
LFSTLifestance Health Group IncSeptember 30, 2025+94.7%$32.1M

Sold off last quarter

  • Astrazeneca PLCCUSIP G0593M107 was $49.3M
  • Ascendis Pharma A/sCUSIP 04351P101 was $26.3M
  • FMSFresenius Medical Care Ag was $17.5M
  • ISRGIntuitive Surgical Inc was $16.1M
  • TARSTarsus Pharmaceuticals Inc was $14.0M
  • GILDGilead Sciences Inc was $13.9M
  • ELANElanco Animal Health Inc was $13.2M
  • DNTHDianthus Therapeutics Inc was $12.6M
  • DXCMDexcom Inc was $11.0M
  • Soleno Therapeutics IncCUSIP 834203309 was $10.9M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+17.9%+14.8%
March 31, 2026−3.7%−4.6%
December 31, 2025+14.6%+2.4%
September 30, 2025+22.8%+7.8%
June 30, 2025+7.2%+10.5%
March 31, 2025−4.0%−4.6%
December 31, 2024−8.3%+2.1%
September 30, 2024+6.1%+5.4%
June 30, 2024−2.7%+4.0%
March 31, 2024+7.8%+10.0%
December 31, 2023+13.7%+11.2%
September 30, 2023−12.1%−3.6%
June 30, 2023+6.1%+8.3%
March 31, 2023−1.2%+7.0%
December 31, 2022−0.1%+7.1%
September 30, 2022+6.4%−5.3%
June 30, 2022−13.6%−16.5%
March 31, 2022−10.1%−4.9%
December 31, 2021+5.3%+10.7%
September 30, 2021−3.3%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1773206
  2. 2
    Filed August 14, 2026 · accession 0001172661-26-003449